Renovaro Biosciences Denmark ApS — Credit Rating and Financial Key Figures
CVR number: 26027322
Stumpedyssevej 17, 2970 Hørsholm
an@rsgroup.dk
tel: 31334811
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -1 113.73 | - 365.26 | - 211.28 | -1 200.50 | -80.14 |
| Other operating expenses | - 988.92 | ||||
| Total depreciation | -99.41 | -99.14 | -99.13 | -80.90 | -67.87 |
| EBIT | -1 213.13 | - 464.40 | - 310.42 | -2 270.32 | - 148.00 |
| Other financial income | 991.42 | 4 139.88 | |||
| Other financial expenses | -4 114.72 | -3 653.26 | -9 953.59 | -4 032.70 | -6 070.23 |
| Net income from associates (fin.) | 1 846.44 | 983.76 | |||
| Pre-tax profit | -2 490.00 | -3 133.90 | -10 264.00 | -2 163.14 | -6 218.23 |
| Income taxes | 781.92 | ||||
| Net earnings | -1 708.08 | -3 133.90 | -10 264.00 | -2 163.14 | -6 218.23 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible rights | 512.79 | 413.65 | 314.52 | 233.62 | 165.75 |
| Intangible assets total | 512.79 | 413.65 | 314.52 | 233.62 | 165.75 |
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Prepayments and accrued income | 76.69 | 48.46 | -0.00 | ||
| Current other receivables | 13.15 | 10.29 | 0.33 | 11.29 | |
| Short term receivables total | 89.84 | 58.75 | 0.32 | 11.29 | |
| Cash and bank deposits | 5 077.72 | 1 628.61 | 951.83 | 1 221.84 | 1 231.58 |
| Cash and cash equivalents | 5 077.72 | 1 628.61 | 951.83 | 1 221.84 | 1 231.58 |
| Balance sheet total (assets) | 5 680.35 | 2 101.01 | 1 266.67 | 1 466.76 | 1 397.34 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 4 003.09 | 4 003.09 | 4 003.09 | 4 003.09 | 4 003.09 |
| Retained earnings | -66 641.73 | -68 349.81 | -71 483.71 | -81 747.71 | -83 910.85 |
| Profit of the financial year | -1 708.08 | -3 133.90 | -10 264.00 | -2 163.14 | -6 218.23 |
| Shareholders equity total | -64 346.72 | -67 480.62 | -77 744.62 | -79 907.76 | -86 125.99 |
| Non-current owed to group member | 69 191.28 | 68 738.40 | 78 648.29 | 81 230.60 | 87 287.42 |
| Non-current liabilities total | 69 191.28 | 68 738.40 | 78 648.29 | 81 230.60 | 87 287.42 |
| Current trade creditors | 835.80 | 843.23 | 363.00 | 81.97 | 60.00 |
| Other non-interest bearing current liabilities | 61.95 | 175.91 | |||
| Current liabilities total | 835.80 | 843.23 | 363.00 | 143.92 | 235.91 |
| Balance sheet total (liabilities) | 5 680.35 | 2 101.01 | 1 266.67 | 1 466.76 | 1 397.34 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.